ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Revive Therapeutics Ltd

Revive Therapeutics Ltd (RVV)

0.015
0.005
(50.00%)
Closed November 19 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.015
Bid
0.01
Ask
0.015
Volume
30,000
0.015 Day's Range 0.015
0.005 52 Week Range 0.04
Previous Close
0.01
Open
0.015
Last Trade
15000
@
0.015
Last Trade Time
Average Volume (3m)
386,453
Financial Volume
-
VWAP
-

RVV Latest News

Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19

  Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19   TORONTO, Canada -- April 18, 2022 -- InvestorsHub NewsWire -- Revive...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

  Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   TORONTO, Canada -- April 12, 2022 -- InvestorsHub NewsWire -- Revive...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   Expected to seek DSMB approval to proceed with EUA application to the FDA in...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19Ethics Committee approval to proceed with Phase 3 clinical trial in Turkey13 clinical sites selected to...

Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

Β Revive Therapeutics Provides Update of Psilocybin Pharmaceutical ProgramsΒ IRB approval to initiate Phase 2 study for methamphetamine abuse disordersΒ Advancing psilocybin oral thin film...

Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19

Β Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19Β Approximately 700 subjects participated in the enrollment periodExpected to begin subject enrollment...

Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer

Β Β Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat CancerΒ Novel discovery and research originated from Universidad Central del...

Revive Confirms No Material Undisclosed Information

  Revive Confirms No Material Undisclosed Information   Toronto, Ontario, Canada -- August 12, 2021 -- InvestorsHub NewsWire -- Revive Therapeutics Ltd...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.005500.010.0150.0057663410.01CS
40.005500.010.0150.0052681560.00888987CS
12000.0150.020.0053864530.00930536CS
26-0.01-400.0250.030.0054510410.0123465CS
52-0.01-400.0250.040.0053093990.01730865CS
156-0.495-97.05882352940.510.560.0053412500.15003148CS
260-0.02-57.14285714290.0350.920.0058646780.31079606CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SPFYSpacefy Inc
$ 0.015
(200.00%)
3.5k
SQXSquatex Energy and Ressources Inc
$ 0.01
(100.00%)
142k
ASEPASEP Medical Holdings Inc
$ 0.055
(57.14%)
21.04k
AMMPAmmPower Corp
$ 0.045
(50.00%)
2.44M
NERDNerds On Site Inc
$ 0.045
(50.00%)
15k
AITTTrenchant Technologies Capital Corp
$ 0.005
(-83.33%)
20k
MYNDMYND Life Sciences Inc
$ 0.05
(-64.29%)
79.28k
URMFirst American Uranium Inc
$ 0.02
(-60.00%)
198.13k
PDOPUDO Inc
$ 0.24
(-55.56%)
3k
PXEP2Earn Inc
$ 0.005
(-50.00%)
4.71k
PLUGEnergy Plug Technologies Corp
$ 0.07
(16.67%)
3.86M
PKKPeak Fintech Group Inc
$ 0.155
(24.00%)
3.23M
BCBCBC Bud Corporation
$ 0.07
(0.00%)
2.8M
SOLSOL Global Investments Corp
$ 0.20
(-13.04%)
2.56M
AMMPAmmPower Corp
$ 0.045
(50.00%)
2.44M

RVV Discussion

View Posts
Milesblue42 Milesblue42 5 days ago
NO PUMP....but a Crazy thought....

1st this is in no way a PUMP Idea.

2nd We don't know if RFK Jr will be confirmed. But just the mention of him being selected by DT sent a lot of BP stocks down.

3rd if RFK Jr is confirmed somehow and his preference for more natural remedies would that make RVVTF finally attractive to BP?


https://www.cnbc.com/2024/11/14/vaccine-maker-stocks-fall-as-trump-chooses-rfk-jr-to-lead-hhs.html
πŸ‘οΈ0
Milesblue42 Milesblue42 5 days ago
Ceo Frank being reported as well???

Forward scamming trust bots to the SEC for making a stock appear to be a scam to newbies.

Pure Comedy 😄
πŸ‘οΈ0
cfoofme cfoofme 5 days ago
Forward scamming trust bots to the SEC for making a stock appear to be a scam to newbies.
πŸ‘οΈ0
TRUSTUNITS1000000 TRUSTUNITS1000000 5 days ago
Price prediction
🥸 1
TRUSTUNITS1000000 TRUSTUNITS1000000 5 days ago
Shareholders post
🤓 1
TRUSTUNITS1000000 TRUSTUNITS1000000 5 days ago
Speculating, wonder if market capitalization, miracle, if goes to billions , maybe fka billion
πŸ‘οΈ0
TRUSTUNITS1000000 TRUSTUNITS1000000 5 days ago
Interesting stock price
πŸ‘οΈ0
TRUSTUNITS1000000 TRUSTUNITS1000000 5 days ago
A lot of debt
πŸ‘οΈ0
TRUSTUNITS1000000 TRUSTUNITS1000000 5 days ago
What makes you come up with $4
πŸ‘οΈ0
Snoop_dog Snoop_dog 1 week ago
$4 might finally be her JFK at the FDA.
πŸ‘οΈ0
Snoop_dog Snoop_dog 1 week ago
They should jump on it H5N1 next COVID.
πŸ‘οΈ0
Snoop_dog Snoop_dog 1 week ago
Any one knows if they work on H5N1?
πŸ‘οΈ0
lolroflmao lolroflmao 1 week ago
Revive Therapeutics Announces Publication Demonstrating Novel Therapeutic Approach of Psilocybin in Stroke Nov 12, 2024

https://revivethera.com/2024/11/revive-therapeutics-announces-publication-demonstrating-novel-therapeutic-approach-of-psilocybin-in-stroke/
👍️ 2 💥 1
lolroflmao lolroflmao 1 week ago


πŸ‘οΈ0
Ecomike Ecomike 2 weeks ago
That dog is all bark and no bite. Ignore him
👎️ 1
Gatorca Gatorca 3 weeks ago
Maybe another possibility If Buc. work 16x nac...Promising Role of N-Acetylcysteine in Reducing Airway Mucus in COPD Patients
https://x.com/ThailandMedicaX/status/1851274249392308675
Hopefully Cw, Rio seen his reply in reddit lol etc they get it to good Use instead of up mfs a ss Monthly 30k salary
πŸ‘οΈ0
lolroflmao lolroflmao 3 weeks ago
News: Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
Oct 31, 2024

https://revivethera.com/2024/10/revive-therapeutics-provides-update-on-research-study-evaluating-bucillamine-for-nerve-agent-exposure-2/
👍️ 1
TRUSTUNITS1000000 TRUSTUNITS1000000 3 weeks ago
One to watch
πŸ‘οΈ0
TRUSTUNITS1000000 TRUSTUNITS1000000 3 weeks ago
0.0001
πŸ‘οΈ0
TRUSTUNITS1000000 TRUSTUNITS1000000 3 weeks ago
Interesting company
πŸ‘οΈ0
Gatorca Gatorca 1 month ago
Derrick might be a better possible Ceo at this point with Shrooms lol ) what about the possible cancer fighting Shrooms?
Ps. Sorry forgot the name of that shroom type possibility..
Pss. Waiting on my Domino's lol..but not Mf. but honestlyhope eventuallyit works our Cw ops 5 shots pizza done heheh..
πŸ‘οΈ0
Gatorca Gatorca 2 months ago
I just hope 🙏 you ok
👍️ 1
Classic Warrior Classic Warrior 2 months ago
Yea. It's my biggest loss, but I my optimism is all but gone. Mistakes were made for sure, but hopefully, the Canadian Department of Defense will see something in the drug and save the day. I still wonder what Derrick has been doing on the psychedelic side and the weed angle. What about those patented strips? I'd say we have about a 3% chance of recovery, but I have been wrong before and hope I am again.

ps. Good luck, but profits elsewhere may be more realistic at this time.
💯 1
Gatorca Gatorca 2 months ago
Just Sucks Cw all I can say now bucy good but Chit ceo etc...
Maybe try some other stocks with some ot money
Ps. Still trying to get it back Lol..but have good chance I think will see...
πŸ‘οΈ0
JoeBenson JoeBenson 2 months ago
Well you should know Giovanni, nobody has spewed more BS on this board than you have.
πŸ‘οΈ0
Giovanni Giovanni 2 months ago
All Is Fine was total BS.
👍️ 2 💯 2
JoeBenson JoeBenson 2 months ago
"What false allegations did MF make?"

πŸ‘οΈ0
Milesblue42 Milesblue42 2 months ago
What do you mean? Explain please

OMG .Oo7 how the long covid. The CEO needs to go to jail!!! Making false allegations about his product. Promises that never came true. Literally he should go to prison for financial fraud. Can't even hold a penny. MF I hope a bus comes by an pick you up. When we will get a new CEO. f joke. I hope he comes to Chicago we could show him the Chicago smile and the hospitality.

What false allegations did MF make?
πŸ‘οΈ0
Snoop_dog Snoop_dog 2 months ago
OMG .Oo7 how the long covid. The CEO needs to go to jail!!! Making false allegations about his product. Promises that never came true. Literally he should go to prison for financial fraud. Can't even hold a penny. MF I hope a bus comes by an pick you up. When we will get a new CEO. f joke. I hope he comes to Chicago we could show him the Chicago smile and the hospitality.
💯 1
Snoop_dog Snoop_dog 2 months ago
OMG .Oo7 how the long covid. The CEO needs to go to jail!!! Making false allegations about his product. Promises that never came true. Literally he should go to prison for financial fraud. Can't even hold a penny. MF I hope a bus comes by an pick you up. When we will get a new CEO. f joke. I hope he comes to Chicago we could show him the Chicago smile and the hospitality.
πŸ‘οΈ0
powerbattles powerbattles 2 months ago
Nobody cares and not enough volume to cover the cost issue of the news.
πŸ‘οΈ0
lolroflmao lolroflmao 2 months ago
NEWS: Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures

SEP 18, 2024


https://revivethera.com/2024/09/revive-therapeutics-announces-strategic-focus-on-bucillamine-for-infectious-diseases-and-medical-countermeasures/
👍️ 1
medicinecat medicinecat 2 months ago
👍️ 1
Hotel Delta Hotel Delta 2 months ago
It'll go back up, buy now if you want to make a little money.
πŸ‘οΈ0
mrfumbles mrfumbles 2 months ago
Down down down
πŸ‘οΈ0
govprs govprs 3 months ago
Omg.
πŸ‘οΈ0
JoeBenson JoeBenson 3 months ago
πŸ‘οΈ0
Classic Warrior Classic Warrior 3 months ago
Almost made back all the money I lost by working overtime, PB. I haven't sold a share but hope for a miracle. If I bought the same number of shares today, I'd own 50% of the company with MF.

ps. more delays. Didn't see that coming although I'm not sure we can blame the big guy for that one. Monkeypox- here we come.
πŸ‘οΈ0
powerbattles powerbattles 3 months ago
Bucillamine showed promise, but MF is a con man. It's very sad to see that MF is taking advantage, he treats shareholders like ATMs to cover his personal expenses. I still see many loyal shareholders posting here. At this point, it's a choice between moving on or holding out for a miracle, which could still happen.
👍️ 1
Milesblue42 Milesblue42 3 months ago
Bucillamine cures every Damn Thing

Is this the Real Deal.....this time?

Will Mr. Frank ever come through??
πŸ‘οΈ0
tradernewstip tradernewstip 3 months ago
$RVVTF Breaking News! Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure and Expansion into Viral Infections https://finance.yahoo.com/news/revive-therapeutics-provides-research-study-110000328.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via
@YahooFinance
πŸ‘οΈ0
Gatorca Gatorca 3 months ago
Yes your right as fck....lol

Ps. But bucillamine can work if the Ceo wasn't such a Dumb ass.....he just want his 30k salary what a piece of Chit yea fo Golfing fck investors his so Dumb .....
πŸ‘οΈ0
MB1972 MB1972 3 months ago
You and everyone else..MF stole all the money from the shareholders collecting a six figure salary and running this into the ground...only a miracle can get us out of this mess imo
👍️ 1 💯 1
govprs govprs 3 months ago
You’re such a bag holder!!!!
πŸ‘οΈ0
govprs govprs 3 months ago
Investing in Rvvtf is like drinking tequila and puking hard


MF is the biggest scam artist. If I could puke all over him right now I would
πŸ‘οΈ0
medicinecat medicinecat 3 months ago
Investing in RVVTF and drinking go together like peanut butter and jelly. Good luck my man.
👍️ 1 💯 1
Gatorca Gatorca 3 months ago
I muted the a hole lol..man really I shouldn't post here when drinking or not invested for now.. some of his post reply seem same as when Mf was a D ick replying to worried investors so maybe u right.. i. I wouldn't put it past Mf
Ps. Cw yes it sucks no vegas meet etc.. and what the fck they tell investors for 18 months we have possible Symptoms data when like the post last week I post....they should of known the trial didn't have Chit for Symptoms the Fda wanted because it was basic;
Ps. Still not giving up on getting money
Back I have a damn good chance wish all rvvtf investors get it back somehow
Pps. I still think bucillamine can still help with many infectious diseases
πŸ‘οΈ0
Gatorca Gatorca 3 months ago
That's why I might buy back if the moons are align lol...
πŸ‘οΈ0
Ecomike Ecomike 3 months ago
Dig back a year or more back and I said here that $RVVTF could and might go after this application, because Bucci had this potential based on what was already known, and what do you know, there it is.

Great post:



Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure

July 02, 2024 13:58 ET

TORONTO, July 02, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (β€œRevive” or the β€œCompany”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders, announced today an update on the research study evaluating Bucillamine as a potential treatment for nerve agent exposure, in partnership with Defence R&D Canada – Suffield Research Centre (β€œDRDC”), an agency of the Canadian Department of National Defence. The DRDC is investigating pharmacological compounds, including Bucillamine, that can mitigate nerve agent induced brain injury. Control studies have been initiated and the DRDC expects to evaluate the data this month. Treatment studies will follow after the conclusion of the control group evaluation. The research study is expected to be completed in August 2024.

Nerve agents are chemicals that affect the nervous system. Nerve agents are highly toxic regardless of the route of exposure. The main chemical nerve agents that are man-made and manufactured for use in chemical warfare are sarin, soman, tabun and VX. These nerve agents are known to be present in military stockpiles. Exposure to nerve agents can occur due to chemical warfare or accidental release from a military storage facility. Exposure to nerve agents can cause tightness of the chest, excessive salivation, abdominal cramps, diarrhea, blurred vision, tremors, and death.

Recent studies have shown that antioxidant compounds such as n-acetylcysteine (β€œNAC”) could be beneficial in limiting seizure activity and improving the anticonvulsant efficacy of GABA-mediating drugs such as diazepam.

Bucillamine is a significantly more effective antioxidant than NAC and has the potential to provide increased efficacy against seizure activity while limiting the anticoagulant and bleeding event liability observed with NAC. The overall objective of the research project is to investigate pharmacological means for neuroprotection of GABA(A) receptors, which are required for the effectiveness of currently fielded anticonvulsant therapies. Bucillamine and NAC will be evaluated to determine the effect on GABA(A) receptor endocytosis and the effect on diazepam effectiveness in terminating seizures. Any additional antioxidant effects on seizure activity and survival will also be assessed.

The results from this research study, if promising, will determine further studies to facilitate FDA and Health Canada approvals for the use of Bucillamine in nerve agents or organophosphate pesticide poisoning. Also, the Company may explore the potential of Bucillamine for traumatic brain injury caused by concussive or explosive forces.

https://www.globenewswire.com/news-release/2024/07/02/2907735/0/en/Revive-Therapeutics-Provides-Update-on-Research-Study-Evaluating-Bucillamine-for-Nerve-Agent-Exposure.html
👍️ 1
medicinecat medicinecat 3 months ago
Gator Man! What's up. Now all we need is for rickthedickstereo to show up. Wish I had a dime for every lame "poor trial design" excuse from Loser investors. Hear it on damn near every failed trial. Denial is a defense mechanism.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock